An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

Invasive meningococcal disease (IMD) causes significant morbidity and mortality worldwide with serogroup B being the predominant serogroup in Australia and other countries for the past few decades. The licensed 4CMenB vaccine is effective in preventing meningococcal B disease. Emerging evidence sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Helen S., Andraweera, Prabha H., Ward, James, Kaldor, John, Andrews, Ross, Macartney, Kristine, Richmond, Peter, Krause, Vicki, Koehler, Ann, Whiley, David, Giles, Lynne, Webby, Rosalind, D’Antoine, Heather, Karnon, Jonathan, Baird, Rob, Lawrence, Andrew, Petousis-Harris, Helen, De Wals, Philippe, Greenwood-Smith, Belinda, Binks, Michael, Whop, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880162/
https://www.ncbi.nlm.nih.gov/pubmed/35214767
http://dx.doi.org/10.3390/vaccines10020309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880162/
https://www.ncbi.nlm.nih.gov/pubmed/35214767
http://dx.doi.org/10.3390/vaccines10020309

Ejemplares similares